Cargando…

Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has endangered human health and life. This pandemic has changed people's lifestyle and affected the regular delivery of standard cancer treatment. In the present study, we aimed to explore the influencing factors of delayed treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shengdong, Wang, Yanlin, Zhao, Xiaoting, Xu, Fangying, Li, Juncheng, Huang, Tao, Sun, Peng, Li, Lingfan, Ai, Xiang, Xiao, Hualin, Xue, Gang, He, Siyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099139/
https://www.ncbi.nlm.nih.gov/pubmed/35570909
http://dx.doi.org/10.3389/fpubh.2022.808873
_version_ 1784706537516695552
author He, Shengdong
Wang, Yanlin
Zhao, Xiaoting
Xu, Fangying
Li, Juncheng
Huang, Tao
Sun, Peng
Li, Lingfan
Ai, Xiang
Xiao, Hualin
Xue, Gang
He, Siyi
author_facet He, Shengdong
Wang, Yanlin
Zhao, Xiaoting
Xu, Fangying
Li, Juncheng
Huang, Tao
Sun, Peng
Li, Lingfan
Ai, Xiang
Xiao, Hualin
Xue, Gang
He, Siyi
author_sort He, Shengdong
collection PubMed
description BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has endangered human health and life. This pandemic has changed people's lifestyle and affected the regular delivery of standard cancer treatment. In the present study, we aimed to explore the influencing factors of delayed treatment in patients with breast cancer during COVID-19 pandemic. METHODS: This study was a cross-sectional investigation, and the subjects were patients who were discharged from the department of burn and plastic surgery after February 2020. All participants completed this study's online questionnaire based on the WeChat and Wenjuanxing platforms. Levels of anxiety and depression were measured by the Hospital Anxiety and Depression Scale (HADS). Patients were divided into a delay group and non-delay group according to the occurrence of delayed treatment. Univariate analysis was performed by using the t test or chi-square test. A logistic regression model was employed to determine factors associated with delayed treatment. RESULTS: The present study included a total of 397 patients with breast cancer, among whom delayed treatment occurred in 76 patients, accounting for 19.1%. Scores on both the anxiety subscale and depression subscale in delay group were significantly higher than those in non-delay group. Compared with non-delay group, we found that patients in delay group usually had a higher level of education (P = 0.020), worse self-feeling (P = 0.030), poor compliance of medical order (P = 0.042), and a higher prevalence of anxiety (P = 0.004) and depression (P = 0.012). Traffic inconvenience was also an important relevant factor for delayed treatment (P = 0.001). The prevalence of recurrence in delay group was higher than that in non-delay group (P = 0.018). By using logistic multivariate regression analysis, the results revealed that level of education and traffic inconvenience were independent factors influencing delayed treatment in patients with breast cancer during COVID-19 pandemic. CONCLUSION: The prevalence of delayed treatment in patients with breast cancer during COVID-19 pandemic is relatively high. Our findings reveal several influencing factors closely associated with delayed treatment, which is useful information that will be beneficial for patients to receive standardized therapy by taking targeted measures.
format Online
Article
Text
id pubmed-9099139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90991392022-05-14 Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic He, Shengdong Wang, Yanlin Zhao, Xiaoting Xu, Fangying Li, Juncheng Huang, Tao Sun, Peng Li, Lingfan Ai, Xiang Xiao, Hualin Xue, Gang He, Siyi Front Public Health Public Health BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has endangered human health and life. This pandemic has changed people's lifestyle and affected the regular delivery of standard cancer treatment. In the present study, we aimed to explore the influencing factors of delayed treatment in patients with breast cancer during COVID-19 pandemic. METHODS: This study was a cross-sectional investigation, and the subjects were patients who were discharged from the department of burn and plastic surgery after February 2020. All participants completed this study's online questionnaire based on the WeChat and Wenjuanxing platforms. Levels of anxiety and depression were measured by the Hospital Anxiety and Depression Scale (HADS). Patients were divided into a delay group and non-delay group according to the occurrence of delayed treatment. Univariate analysis was performed by using the t test or chi-square test. A logistic regression model was employed to determine factors associated with delayed treatment. RESULTS: The present study included a total of 397 patients with breast cancer, among whom delayed treatment occurred in 76 patients, accounting for 19.1%. Scores on both the anxiety subscale and depression subscale in delay group were significantly higher than those in non-delay group. Compared with non-delay group, we found that patients in delay group usually had a higher level of education (P = 0.020), worse self-feeling (P = 0.030), poor compliance of medical order (P = 0.042), and a higher prevalence of anxiety (P = 0.004) and depression (P = 0.012). Traffic inconvenience was also an important relevant factor for delayed treatment (P = 0.001). The prevalence of recurrence in delay group was higher than that in non-delay group (P = 0.018). By using logistic multivariate regression analysis, the results revealed that level of education and traffic inconvenience were independent factors influencing delayed treatment in patients with breast cancer during COVID-19 pandemic. CONCLUSION: The prevalence of delayed treatment in patients with breast cancer during COVID-19 pandemic is relatively high. Our findings reveal several influencing factors closely associated with delayed treatment, which is useful information that will be beneficial for patients to receive standardized therapy by taking targeted measures. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9099139/ /pubmed/35570909 http://dx.doi.org/10.3389/fpubh.2022.808873 Text en Copyright © 2022 He, Wang, Zhao, Xu, Li, Huang, Sun, Li, Ai, Xiao, Xue and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
He, Shengdong
Wang, Yanlin
Zhao, Xiaoting
Xu, Fangying
Li, Juncheng
Huang, Tao
Sun, Peng
Li, Lingfan
Ai, Xiang
Xiao, Hualin
Xue, Gang
He, Siyi
Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title_full Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title_fullStr Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title_full_unstemmed Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title_short Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic
title_sort factors influencing delayed treatment in patients with breast cancer during covid-19 pandemic
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099139/
https://www.ncbi.nlm.nih.gov/pubmed/35570909
http://dx.doi.org/10.3389/fpubh.2022.808873
work_keys_str_mv AT heshengdong factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT wangyanlin factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT zhaoxiaoting factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT xufangying factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT lijuncheng factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT huangtao factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT sunpeng factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT lilingfan factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT aixiang factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT xiaohualin factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT xuegang factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic
AT hesiyi factorsinfluencingdelayedtreatmentinpatientswithbreastcancerduringcovid19pandemic